Author: GlobeNewswire

SUZHOU, China and PALO ALTO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) — Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global…

NORTHBROOK, Ill., Nov. 17, 2021 (GLOBE NEWSWIRE) — Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing…

COPENHAGEN, Denmark, Nov. 17, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company is scheduled…

WATERTOWN, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and…

Atea to lead global clinical trial development of AT-527 and regain ex-US commercial rightsBOSTON, Nov. 16, 2021 (GLOBE NEWSWIRE) —…

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its…

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomics and precision medicine, is pleased…

SCOTTSDALE, Ariz., Nov. 16, 2021 (GLOBE NEWSWIRE) — Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that…

WINNIPEG, Manitoba, Nov. 16, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today…

Management Team Will Present on Company’s Strategy Going Forward VANCOUVER, Washington, Nov. 16, 2021 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB:…